ALBO
Albireo Pharma Inc
ALBO
ALBO
Delisted
ALBO was delisted on the 2nd of March, 2023.
107 hedge funds and large institutions have $621M invested in Albireo Pharma Inc in 2020 Q4 according to their latest regulatory filings, with 23 funds opening new positions, 44 increasing their positions, 30 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
1% less funds holding
Funds holding: 108 → 107 (-1)
68% less call options, than puts
Call options by funds: $1.87M | Put options by funds: $5.87M
Holders
107
Holding in Top 10
2
Calls
$1.87M
Puts
$5.87M
Top Buyers
| 1 | +$22.5M | |
| 2 | +$20.9M | |
| 3 | +$11.5M | |
| 4 |
Goldman Sachs
New York
|
+$6.53M |
| 5 |
RHJA
Rice Hall James & Associates
San Diego,
California
|
+$6.38M |
Top Sellers
| 1 | -$20M | |
| 2 | -$11M | |
| 3 | -$7.5M | |
| 4 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
-$5.79M |
| 5 |
AG
Artal Group
Luxembourg
|
-$5.68M |